Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
Published on: May 27, 2026, 8:27 p.m. | Source: The Economic Times
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affordable.
